One-day DCF regimen in patients with metastatic gastric cancer

Dirican, Ahmet; Kucukzeybek, Yuksel; Tarhan, Mustafa; Somali, Isil; Erten, Cigdem; DEMİR, LÜTFİYE; Can, Alper; Bayoglu, Ibrahim; Akyol, Murat; Ekinci, Nese; Medeni, Murat; Koyuncu, Betul; Alacacioglu, Ahmet

doi:10.1700/1283.14183

One-day DCF regimen in patients with metastatic gastric cancer

Dirican A., Kucukzeybek Y., Tarhan M. O., Somali I., Erten C., DEMİR L., ...More

TUMORI J, vol.99, no.2, pp.145-148, 2013 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 99 Issue: 2
Publication Date: 2013
Doi Number: 10.1700/1283.14183
Journal Name: TUMORI J
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.145-148
Eskisehir Osmangazi University Affiliated: No

Abstract

Background. Cytotoxic chemotherapy is the basic treatment for metastatic gastric cancer. The "docetaxel, cisplatin, 5-day infusion of 5-FU (DCF5)" regimen is regarded as an effective therapy. However, the poor toxicity profile of this regimen and administration by 5-day infusion are major drawbacks of this method.